Can the SARS-CoV-2 serological ELISA kits assess the effectiveness of a SARS-CoV-2 vaccine using vaccine-injected human blood samples?

Yes, potentially all of our SARS-CoV-2 serological ELISA kits could be useful for studying samples from vaccine-injected subjects. Please follow this link for a list of all currently available kits. Please note that we have not tested the SARS-CoV-2 serological ELISA kits on samples from vaccinated people in-house, but they should work in a similar manner as they do for samples from previously infected patients.

Last updated: September 12, 2024